Kepler Cheuvreux Suisse SA cut its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 72.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 38,297 shares of the company's stock after selling 101,558 shares during the period. Kepler Cheuvreux Suisse SA's holdings in Procter & Gamble were worth $5,488,000 at the end of the most recent reporting period.
Other large investors have also recently made changes to their positions in the company. Maseco LLP bought a new stake in shares of Procter & Gamble in the 4th quarter worth about $28,000. Saranac Partners Ltd bought a new stake in shares of Procter & Gamble in the 3rd quarter worth about $30,000. Corundum Trust Company INC bought a new stake in shares of Procter & Gamble in the 3rd quarter worth about $32,000. Caitlin John LLC bought a new stake in shares of Procter & Gamble in the 3rd quarter worth about $34,000. Finally, Anfield Capital Management LLC increased its holdings in shares of Procter & Gamble by 121.5% in the 4th quarter. Anfield Capital Management LLC now owns 237 shares of the company's stock worth $34,000 after buying an additional 130 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.
Procter & Gamble News Summary
Here are the key news stories impacting Procter & Gamble this week:
Insider Buying and Selling
In other Procter & Gamble news, CEO Gary A. Coombe sold 36,093 shares of the business's stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $162.33, for a total value of $5,858,976.69. Following the completion of the sale, the chief executive officer directly owned 34,994 shares of the company's stock, valued at $5,680,576.02. The trade was a 50.77% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Susan Street Whaley sold 1,809 shares of the business's stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $159.46, for a total transaction of $288,463.14. Following the completion of the sale, the insider owned 30,215 shares of the company's stock, valued at approximately $4,818,083.90. This represents a 5.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 244,715 shares of company stock worth $39,702,904 over the last 90 days. Corporate insiders own 0.20% of the company's stock.
Analyst Ratings Changes
A number of analysts have recently weighed in on the stock. TD Cowen boosted their target price on shares of Procter & Gamble from $142.00 to $150.00 and gave the stock a "hold" rating in a report on Monday, April 27th. Royal Bank Of Canada dropped their price target on shares of Procter & Gamble from $172.00 to $167.00 and set an "outperform" rating for the company in a research note on Thursday, April 9th. Evercore set a $162.00 price target on shares of Procter & Gamble in a research note on Monday, April 27th. Bank of America dropped their price target on shares of Procter & Gamble from $171.00 to $167.00 and set a "buy" rating for the company in a research note on Friday, April 10th. Finally, UBS Group lifted their price target on shares of Procter & Gamble from $166.00 to $172.00 and gave the stock a "buy" rating in a research note on Monday, April 27th. Eleven investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $161.06.
View Our Latest Analysis on Procter & Gamble
Procter & Gamble Price Performance
Procter & Gamble stock opened at $146.44 on Monday. The stock has a market cap of $341.00 billion, a price-to-earnings ratio of 21.41, a price-to-earnings-growth ratio of 6.28 and a beta of 0.41. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $170.99. The firm has a 50-day moving average of $148.41 and a two-hundred day moving average of $148.55.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.56 by $0.03. The company had revenue of $21.24 billion during the quarter, compared to analysts' expectations of $21.52 billion. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The firm's quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.54 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 24th will be given a $1.0885 dividend. This is a positive change from Procter & Gamble's previous quarterly dividend of $1.06. The ex-dividend date of this dividend is Friday, April 24th. This represents a $4.35 annualized dividend and a yield of 3.0%. Procter & Gamble's dividend payout ratio is presently 63.60%.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.